CUPRIC CHLORIDE
Generic: CUPRIC CHLORIDE
Somerset TherapeuticsManufacturer
INTRAVENOUSRoute
CUPRIC CHLORIDEActive Substance
2024-04-30Original Approval
CUPRIC CHLORIDE is FDA application ANDA216113, sponsored by SOMERSET. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HEPATITIS
2 reports
2
ACUTE RESPIRATORY FAILURE
1 reports
3
ANAEMIA
1 reports
4
BLOOD POTASSIUM DECREASED
1 reports
5
BONE MARROW FAILURE
1 reports
6
CERULOPLASMIN DECREASED
1 reports
7
COPPER DEFICIENCY
1 reports
8
COVID-19
1 reports
9
DEATH
1 reports
10
DISTURBANCE IN ATTENTION
1 reports